Form4insider filings, from the source

SEC Form 4 · accession 0000899243-19-005262

GW PHARMACEUTICALS PLC · GWPH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Volker Knappertz
Officer — Chief Medical Officer
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1,F2Feb 26, 2019M8,436$0.0013A16,608D
Ordinary SharesF3,F4Feb 26, 2019S504$12.44D16,104D
Ordinary SharesF3,F4Feb 26, 2019S3,600$12.46D12,504D
Ordinary SharesF3,F4Feb 26, 2019S36$12.29D12,468D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock OptionsF2$0.0013Feb 26, 2019M8,436DFeb 26, 2019Mar 15, 2020Ordinary Shares8,4366D

Explanation of responses